美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Estrella Immunopharma

0.8785

+0.04705.65%

成交量：1.71万

成交额：1.50万

市值：3,177.15万

市盈率：-3.62

高：0.8990

开：0.8739

低：0.8475

收：0.8315

数据加载中...

总览公司新闻公告

Estrella Immunopharma, Inc.股价飙升13.42% 市值涨820.54万美元

Estrella Immunopharma, Inc.盘中异动快速上涨12.15%

Estrella Immunopharma(ESLA.US)获D. Boral Capital首次覆盖，给予买入评级, 目标价16.00美元。

Estrella Immunopharma, Inc.股价拉升12.38% 市值涨188.69万美元

Estrella Immunopharma, Inc.盘中异动快速上涨5.31%

Estrella Immunopharma, Inc.盘中异动临近收盘急速拉升6.54%报1.14美元

Estrella Immunopharma, Inc.盘中异动早盘股价大跌5.36%

Estrella Immunopharma, Inc.盘中异动大幅拉升8.68%

Estrella Immunopharma, Inc.盘中异动下午盘快速上涨6.67%报1.12美元

Estrella Immunopharma, Inc.盘中异动股价大跌5.36%

Estrella Immunopharma, Inc.盘中异动快速跳水5.43%

Estrella Immunopharma, Inc.盘中异动快速跳水5.51%报1.12美元

Estrella Immunopharma, Inc.盘中异动股价大跌5.42%

Estrella Immunopharma, Inc.股价拉升10.62% 市值涨488.66万美元

Estrella Immunopharma, Inc.盘中异动早盘快速下挫5.08%

Estrella Immunopharma, Inc.盘中异动急速下跌8.11%报1.02美元

Estrella Immunopharma, Inc.盘中异动快速下跌10.08%

Estrella Immunopharma, Inc.盘中异动大幅下挫6.10%报1.08美元

Estrella Immunopharma, Inc.盘中异动下午盘急速跳水5.65%报1.17美元

Estrella Immunopharma, Inc.盘中异动股价大涨7.48%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/ESLA/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":0.8785,"timestamp":1745352000000,"preClose":0.8315,"halted":0,"volume":17137,"delay":0,"floatShares":9912119,"shares":36165589,"eps":-0.242472,"marketStatus":"未开盘","change":0.047,"latestTime":"04-22 16:00:00 EDT","open":0.8739,"high":0.899,"low":0.8475,"amount":14964.224073,"amplitude":0.061936,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.242472,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.8315,"volumeRatio":0.49192},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESLA\",,,,,undefined,":{"symbol":"ESLA","floatShares":9912119,"roa":"-35.45%","roe":"-163.06%","lyrEps":-0.121236,"volumeRatio":0.49192,"shares":36165589,"dividePrice":0,"high":0.899,"amplitude":0.061936,"preClose":0.8315,"low":0.8475,"week52Low":0.63,"pbRate":"221.05","week52High":3.23,"institutionHeld":0,"latestPrice":0.8785,"eps":-0.242472,"divideRate":0,"volume":17137,"delay":0,"ttmEps":-0.242472,"open":0.8739,"prevYearClose":1.2,"prevWeekClose":0.7936,"prevMonthClose":0.927,"prevQuarterClose":0.927,"fiveDayClose":0.8749,"twentyDayClose":0.9898,"sixtyDayClose":1.13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESLA\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2513296581","title":"Estrella Immunopharma, Inc.股价飙升13.42% 市值涨820.54万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513296581?lang=zh_cn&edition=fundamental","pubTime":"2025-02-21 22:31","pubTimestamp":1740148262,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Estrella Immunopharma, Inc.股票出现异动，股价大幅上涨13.42%。截至发稿，该股报1.69美元/股，成交量10.6477万股，换手率0.29%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223102a24eaff6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223102a24eaff6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2512166470","title":"Estrella Immunopharma, Inc.盘中异动 快速上涨12.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512166470?lang=zh_cn&edition=fundamental","pubTime":"2025-02-18 22:32","pubTimestamp":1739889130,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Estrella Immunopharma, Inc.股票出现波动，股价快速拉升12.15%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Glycomimetics, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为276.23%、91.16%、60.68%，振幅较大的相关个股有Allogene Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Allakos Inc.，振幅分别为9.56%、8.57%、8.35%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223210a24aacc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223210a24aacc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2512519901","title":"Estrella Immunopharma(ESLA.US)获D. Boral Capital首次覆盖，给予买入评级, 目标价16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512519901","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512519901?lang=zh_cn&edition=fundamental","pubTime":"2025-02-18 20:24","pubTimestamp":1739881496,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma(ESLA.US)获D. Boral Capital首次覆盖，给予买入评级, 目标价16.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/18202448237104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ESLA"],"gpt_icon":0},{"id":"2511716697","title":"Estrella Immunopharma, Inc.股价拉升12.38% 市值涨188.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511716697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511716697?lang=zh_cn&edition=fundamental","pubTime":"2025-02-15 00:41","pubTimestamp":1739551271,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日00时41分，Estrella Immunopharma, Inc.股票出现异动，股价快速拉升12.38%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021500411196233933&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021500411196233933&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2511269525","title":"Estrella Immunopharma, Inc.盘中异动 快速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511269525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511269525?lang=zh_cn&edition=fundamental","pubTime":"2025-02-13 22:43","pubTimestamp":1739457781,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时43分，Estrella Immunopharma, Inc.股票出现波动，股价急速拉升5.31%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224301a244adf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224301a244adf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2510526303","title":"Estrella Immunopharma, Inc.盘中异动 临近收盘急速拉升6.54%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510526303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510526303?lang=zh_cn&edition=fundamental","pubTime":"2025-02-12 04:50","pubTimestamp":1739307015,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日04时50分，Estrella Immunopharma, Inc.股票出现异动，股价大幅拉升6.54%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为2.02%。其相关个股中，Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3245.87%、1559.43%、521.43%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、72.23%、64.94%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120450159881f924&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120450159881f924&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2510613238","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510613238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510613238?lang=zh_cn&edition=fundamental","pubTime":"2025-02-10 23:44","pubTimestamp":1739202242,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时44分，Estrella Immunopharma, Inc.股票出现波动，股价快速跳水5.36%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234402abc9b513&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210234402abc9b513&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2509248270","title":"Estrella Immunopharma, Inc.盘中异动 大幅拉升8.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509248270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509248270?lang=zh_cn&edition=fundamental","pubTime":"2025-02-06 22:31","pubTimestamp":1738852265,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时31分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨8.68%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223105961a190e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223105961a190e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2508129263","title":"Estrella Immunopharma, Inc.盘中异动 下午盘快速上涨6.67%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508129263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508129263?lang=zh_cn&edition=fundamental","pubTime":"2025-02-04 02:06","pubTimestamp":1738605964,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日02时06分，Estrella Immunopharma, Inc.股票出现波动，股价快速上涨6.67%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Invivyd, Inc.、Hcw Biologics Inc.、Gh Research Plc涨幅较大，Hcw Biologics Inc.、Cyclerion Therapeutics, Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为693.66%、591.49%、461.96%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为170.13%、126.64%、63.94%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020402060498798d30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020402060498798d30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2507698799","title":"Estrella Immunopharma, Inc.盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507698799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507698799?lang=zh_cn&edition=fundamental","pubTime":"2025-01-31 22:54","pubTimestamp":1738335243,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时54分，Estrella Immunopharma, Inc.股票出现波动，股价大幅下跌5.36%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.52%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131225403abbe3fd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131225403abbe3fd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2506512962","title":"Estrella Immunopharma, Inc.盘中异动 快速跳水5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506512962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506512962?lang=zh_cn&edition=fundamental","pubTime":"2025-01-28 23:03","pubTimestamp":1738076581,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时03分，Estrella Immunopharma, Inc.股票出现波动，股价大幅跳水5.43%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128230301abbb6d2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128230301abbb6d2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2506086056","title":"Estrella Immunopharma, Inc.盘中异动 快速跳水5.51%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506086056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506086056?lang=zh_cn&edition=fundamental","pubTime":"2025-01-25 00:13","pubTimestamp":1737735183,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时13分，Estrella Immunopharma, Inc.股票出现异动，股价大幅下跌5.51%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125001303abb7665e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125001303abb7665e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2505208226","title":"Estrella Immunopharma, Inc.盘中异动 股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505208226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505208226?lang=zh_cn&edition=fundamental","pubTime":"2025-01-22 00:02","pubTimestamp":1737475321,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日00时02分，Estrella Immunopharma, Inc.股票出现波动，股价急速下跌5.42%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.66%。其相关个股中，Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为747.15%、452.78%、179.80%，振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.，振幅分别为96.32%、41.33%、38.48%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122000202a22a6b72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122000202a22a6b72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2504943353","title":"Estrella Immunopharma, Inc.股价拉升10.62% 市值涨488.66万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504943353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504943353?lang=zh_cn&edition=fundamental","pubTime":"2025-01-17 01:40","pubTimestamp":1737049242,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日01时40分，Estrella Immunopharma, Inc.股票出现波动，股价大幅拉升10.62%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117014043abad78f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117014043abad78f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0},{"id":"2503371572","title":"Estrella Immunopharma, Inc.盘中异动 早盘快速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503371572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503371572?lang=zh_cn&edition=fundamental","pubTime":"2025-01-14 23:07","pubTimestamp":1736867222,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日23时07分，Estrella Immunopharma, Inc.股票出现波动，股价急速下挫5.08%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114230702a221c0f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114230702a221c0f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2502153892","title":"Estrella Immunopharma, Inc.盘中异动 急速下跌8.11%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502153892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502153892?lang=zh_cn&edition=fundamental","pubTime":"2025-01-11 00:30","pubTimestamp":1736526600,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时30分，Estrella Immunopharma, Inc.股票出现异动，股价急速跳水8.11%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为1.66%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111003000aba61df2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111003000aba61df2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2502775527","title":"Estrella Immunopharma, Inc.盘中异动 快速下跌10.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502775527","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502775527?lang=zh_cn&edition=fundamental","pubTime":"2025-01-09 00:30","pubTimestamp":1736353835,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日00时30分，Estrella Immunopharma, Inc.股票出现波动，股价急速下跌10.08%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109003035aba36615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109003035aba36615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2501809736","title":"Estrella Immunopharma, Inc.盘中异动 大幅下挫6.10%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501809736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501809736?lang=zh_cn&edition=fundamental","pubTime":"2025-01-08 02:37","pubTimestamp":1736275064,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日02时37分，Estrella Immunopharma, Inc.股票出现波动，股价急速下挫6.10%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.25%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108023744aba2132c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108023744aba2132c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2501265891","title":"Estrella Immunopharma, Inc.盘中异动 下午盘急速跳水5.65%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501265891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501265891?lang=zh_cn&edition=fundamental","pubTime":"2025-01-07 02:33","pubTimestamp":1736188402,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日02时33分，Estrella Immunopharma, Inc.股票出现波动，股价快速跳水5.65%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107023323a217c907&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107023323a217c907&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"gpt_icon":0},{"id":"2500114768","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨7.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500114768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500114768?lang=zh_cn&edition=fundamental","pubTime":"2025-01-03 22:36","pubTimestamp":1735915004,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时36分，Estrella Immunopharma, Inc.股票出现异动，股价快速拉升7.48%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223644985a3e8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223644985a3e8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":72,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESLA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1739937600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ESLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ESLA","date":"2025-04-21","current":-3.241379,"percent":0.997222,"low":-10.568666,"twenty":-5.652744,"median":-4.670514,"eighty":-4.117325,"high":-3.104323,"avg":-4.977286,"sd":1.1873,"marketCap":28699347},"quantilePoints":[{"date":"2023-10-13","current":-4.972461,"twenty":-6.796753,"median":-5.384194,"eighty":-5.200498,"marketCap":55265934},{"date":"2023-10-20","current":-4.346628,"twenty":-5.624899,"median":-4.845774,"eighty":-4.503973,"marketCap":48310170},{"date":"2023-10-27","current":-4.814103,"twenty":-5.358857,"median":-4.766595,"eighty":-4.395592,"marketCap":53505872},{"date":"2023-11-03","current":-4.877446,"twenty":-5.358857,"median":-4.877446,"eighty":-4.546793,"marketCap":54209897},{"date":"2023-11-10","current":-4.085653,"twenty":-5.257507,"median":-4.829938,"eighty":-4.367404,"marketCap":45409589},{"date":"2023-11-17","current":-3.800607,"twenty":-5.219501,"median":-4.560729,"eighty":-4.142662,"marketCap":42241478},{"date":"2023-11-24","current":-4.914497,"twenty":-5.067477,"median":-4.560729,"eighty":-4.117325,"marketCap":49633737},{"date":"2023-12-01","current":-5.785861,"twenty":-5.257507,"median":-4.829938,"eighty":-4.244012,"marketCap":58434045},{"date":"2023-12-08","current":-4.18255,"twenty":-5.193333,"median":-4.719087,"eighty":-4.244012,"marketCap":42241478},{"date":"2023-12-15","current":-4.356823,"twenty":-5.067477,"median":-4.653087,"eighty":-4.244012,"marketCap":44001540},{"date":"2023-12-22","current":-4.321969,"twenty":-5.053915,"median":-4.560729,"eighty":-4.244012,"marketCap":43649527},{"date":"2023-12-29","current":-4.008277,"twenty":-5.005043,"median":-4.502348,"eighty":-4.203463,"marketCap":40481416},{"date":"2024-01-05","current":-4.043132,"twenty":-4.967839,"median":-4.461387,"eighty":-4.18255,"marketCap":40833429},{"date":"2024-01-12","current":-3.520313,"twenty":-4.949351,"median":-4.397024,"eighty":-4.086666,"marketCap":35553244},{"date":"2024-01-19","current":-3.555168,"twenty":-4.949351,"median":-4.37517,"eighty":-4.043132,"marketCap":35905256},{"date":"2024-01-26","current":-4.217405,"twenty":-4.914497,"median":-4.391678,"eighty":-4.043132,"marketCap":42593490},{"date":"2024-02-02","current":-4.217405,"twenty":-4.914497,"median":-4.356823,"eighty":-4.022309,"marketCap":42593490},{"date":"2024-02-09","current":-4.008626,"twenty":-4.879642,"median":-4.356475,"eighty":-4.008626,"marketCap":40484936},{"date":"2024-02-16","current":-3.79915,"twenty":-4.877446,"median":-4.314662,"eighty":-4.008277,"marketCap":38369342},{"date":"2024-02-23","current":-4.421106,"twenty":-4.852108,"median":-4.351551,"eighty":-4.008277,"marketCap":36976978},{"date":"2024-03-01","current":-4.46488,"twenty":-4.845774,"median":-4.356823,"eighty":-4.008556,"marketCap":37343087},{"date":"2024-03-08","current":-4.683308,"twenty":-4.845774,"median":-4.37517,"eighty":-4.008626,"marketCap":39169969},{"date":"2024-03-15","current":-4.508653,"twenty":-4.845774,"median":-4.391678,"eighty":-4.019572,"marketCap":37709196},{"date":"2024-03-22","current":-4.727519,"twenty":-4.845774,"median":-4.421106,"eighty":-4.038967,"marketCap":39539739},{"date":"2024-03-28","current":-5.471666,"twenty":-4.878324,"median":-4.421106,"eighty":-4.043132,"marketCap":45763587},{"date":"2024-04-05","current":-4.990159,"twenty":-4.946386,"median":-4.434042,"eighty":-4.068645,"marketCap":41736391},{"date":"2024-04-12","current":-4.771293,"twenty":-4.947572,"median":-4.461387,"eighty":-4.088693,"marketCap":39905848},{"date":"2024-04-19","current":-4.508653,"twenty":-4.946386,"median":-4.46488,"eighty":-4.106683,"marketCap":37709196},{"date":"2024-04-26","current":-4.552426,"twenty":-4.946123,"median":-4.508653,"eighty":-4.135548,"marketCap":38075304},{"date":"2024-05-03","current":-4.604954,"twenty":-4.927077,"median":-4.543309,"eighty":-4.168608,"marketCap":38514635},{"date":"2024-05-10","current":-4.683746,"twenty":-4.914497,"median":-4.525981,"eighty":-4.18255,"marketCap":39173630},{"date":"2024-05-17","current":-6.309978,"twenty":-4.927077,"median":-4.552426,"eighty":-4.18255,"marketCap":38441413},{"date":"2024-05-24","current":-6.009503,"twenty":-4.949351,"median":-4.552645,"eighty":-4.18255,"marketCap":36610870},{"date":"2024-05-31","current":-5.254478,"twenty":-5.016423,"median":-4.56334,"eighty":-4.196492,"marketCap":32011137},{"date":"2024-06-07","current":-5.573329,"twenty":-5.126143,"median":-4.595762,"eighty":-4.217405,"marketCap":33953631},{"date":"2024-06-14","current":-5.672448,"twenty":-5.245388,"median":-4.604954,"eighty":-4.217405,"marketCap":34557478},{"date":"2024-06-21","current":-5.254478,"twenty":-5.254478,"median":-4.639973,"eighty":-4.217405,"marketCap":32011137},{"date":"2024-06-28","current":-5.553028,"twenty":-5.257507,"median":-4.639973,"eighty":-4.217405,"marketCap":33829952},{"date":"2024-07-05","current":-6.836793,"twenty":-5.380881,"median":-4.661859,"eighty":-4.222726,"marketCap":41650855},{"date":"2024-07-12","current":-8.120557,"twenty":-5.46684,"median":-4.674942,"eighty":-4.245731,"marketCap":49471758},{"date":"2024-07-15","current":-8.478817,"twenty":-5.484657,"median":-4.679369,"eighty":-4.24745,"marketCap":51654336},{"date":"2024-08-02","current":-10.568666,"twenty":-5.500483,"median":-4.681339,"eighty":-4.24917,"marketCap":64386038},{"date":"2024-08-09","current":-8.299687,"twenty":-5.526159,"median":-4.683746,"eighty":-4.266453,"marketCap":50563047},{"date":"2024-08-16","current":-8.419107,"twenty":-5.589093,"median":-4.694558,"eighty":-4.282332,"marketCap":51290573},{"date":"2024-08-23","current":-7.881717,"twenty":-5.717813,"median":-4.727519,"eighty":-4.286974,"marketCap":48016706},{"date":"2024-08-30","current":-6.896503,"twenty":-6.017985,"median":-4.738462,"eighty":-4.287114,"marketCap":42014618},{"date":"2024-09-06","current":-6.329258,"twenty":-6.201587,"median":-4.792698,"eighty":-4.288183,"marketCap":38558870},{"date":"2024-09-13","current":-7.045778,"twenty":-6.309738,"median":-4.815066,"eighty":-4.296814,"marketCap":42924025},{"date":"2024-09-20","current":-5.76261,"twenty":-6.309738,"median":-4.815066,"eighty":-4.313201,"marketCap":35106760},{"date":"2024-09-27","current":-5.791271,"twenty":-6.293445,"median":-4.845774,"eighty":-4.331833,"marketCap":35281366},{"date":"2024-10-04","current":-5.494176,"twenty":-6.293445,"median":-4.868142,"eighty":-4.350567,"marketCap":40171894},{"date":"2024-10-11","current":-4.148845,"twenty":-6.216784,"median":-4.858839,"eighty":-4.350567,"marketCap":30335209},{"date":"2024-10-18","current":-4.157755,"twenty":-6.122441,"median":-4.845774,"eighty":-4.288183,"marketCap":30400352},{"date":"2024-10-25","current":-4.212202,"twenty":-6.099645,"median":-4.815066,"eighty":-4.286905,"marketCap":30798452},{"date":"2024-10-31","current":-4.032032,"twenty":-6.085858,"median":-4.815066,"eighty":-4.286835,"marketCap":29481103},{"date":"2024-11-08","current":-3.964716,"twenty":-6.030708,"median":-4.792698,"eighty":-4.245731,"marketCap":28988907},{"date":"2024-11-15","current":-4.157755,"twenty":-6.026467,"median":-4.727519,"eighty":-4.217405,"marketCap":30400352},{"date":"2024-11-22","current":-3.652759,"twenty":-6.001802,"median":-4.723303,"eighty":-4.18255,"marketCap":32209897},{"date":"2024-11-29","current":-4.656782,"twenty":-5.970998,"median":-4.694558,"eighty":-4.18255,"marketCap":41063331},{"date":"2024-12-06","current":-5.005528,"twenty":-5.961427,"median":-4.719087,"eighty":-4.18255,"marketCap":44138559},{"date":"2024-12-13","current":-5.066661,"twenty":-5.907942,"median":-4.727519,"eighty":-4.18255,"marketCap":44677628},{"date":"2024-12-20","current":-4.513181,"twenty":-5.895445,"median":-4.727519,"eighty":-4.18255,"marketCap":39797061},{"date":"2024-12-27","current":-4.800383,"twenty":-5.891211,"median":-4.759354,"eighty":-4.202312,"marketCap":42329601},{"date":"2025-01-03","current":-4.595649,"twenty":-5.831182,"median":-4.759354,"eighty":-4.210222,"marketCap":40524262},{"date":"2025-01-10","current":-4.55421,"twenty":-5.791868,"median":-4.759354,"eighty":-4.214283,"marketCap":40158853},{"date":"2025-01-17","current":-4.808589,"twenty":-5.791868,"median":-4.765324,"eighty":-4.217405,"marketCap":42401960},{"date":"2025-01-24","current":-4.841412,"twenty":-5.791749,"median":-4.765324,"eighty":-4.217405,"marketCap":42691393},{"date":"2025-01-31","current":-4.595239,"twenty":-5.790189,"median":-4.759354,"eighty":-4.217405,"marketCap":40520644},{"date":"2025-02-07","current":-4.718325,"twenty":-5.781211,"median":-4.75438,"eighty":-4.222726,"marketCap":41606019},{"date":"2025-02-14","current":-4.636268,"twenty":-5.75842,"median":-4.727519,"eighty":-4.245731,"marketCap":40882436},{"date":"2025-02-21","current":-6.113309,"twenty":-5.785861,"median":-4.749406,"eighty":-4.252608,"marketCap":53906929},{"date":"2025-02-28","current":-3.938776,"twenty":-5.785861,"median":-4.75438,"eighty":-4.252608,"marketCap":34731981},{"date":"2025-03-07","current":-4.061863,"twenty":-5.76261,"median":-4.727519,"eighty":-4.217405,"marketCap":35817355},{"date":"2025-03-14","current":-4.184949,"twenty":-5.741662,"median":-4.718911,"eighty":-4.212202,"marketCap":36902729},{"date":"2025-03-21","current":-3.781635,"twenty":-5.692164,"median":-4.717095,"eighty":-4.184949,"marketCap":33346319},{"date":"2025-03-28","current":-3.800136,"twenty":-5.672448,"median":-4.683746,"eighty":-4.18255,"marketCap":33646606},{"date":"2025-04-04","current":-3.839558,"twenty":-5.66199,"median":-4.683746,"eighty":-4.157755,"marketCap":33995653},{"date":"2025-04-11","current":-3.717019,"twenty":-5.653341,"median":-4.678332,"eighty":-4.145266,"marketCap":32910685},{"date":"2025-04-17","current":-3.41639,"twenty":-5.652863,"median":-4.673905,"eighty":-4.117991,"marketCap":30248898},{"date":"2025-04-21","current":-3.241379,"twenty":-5.652744,"median":-4.670514,"eighty":-4.117325,"marketCap":28699347}],"updateTime":1745387860816}}}